Longitudinal Study for Central Nervous System Vasculitis

Launched by UNIVERSITY OF PENNSYLVANIA · Feb 8, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a serious condition called primary central nervous system vasculitis (CNSV), which can cause a variety of neurological problems, including strokes, memory issues, and even loss of vision. The goal of the study is to gather information about how this disease develops, how it can be treated, and what outcomes patients experience. Researchers are currently looking for participants who are at least 18 years old and have been diagnosed with CNSV. To be eligible, individuals must show specific signs of the disease and should not have other conditions that could explain their symptoms.

Participants in this study can expect to undergo evaluations that will help researchers better understand CNSV. This may involve tests and assessments related to their neurological health. It’s important to note that participants will need to agree to join the study by signing an informed consent form. This trial is open to anyone regardless of gender, and it aims to improve the understanding of CNSV to help future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • i. Diagnostic criteria for CNSV
• • 1. The presence of an acquired and otherwise unexplained neurologic deficit
• • 2. The presence of either classic angiographic or histopathologic features of angiitis in the CNS
• • 3. No evidence of systemic vasculitis or any condition that could cause the angiographic or pathologic features
• • ii. ≥18 years of age
• Exclusion Criteria:
• • i. Unwilling to sign informed consent.